Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for fecal incontinence in children with functional constipation
IRCT20200203046352N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional constipation (FC) comparing Risperidone with Placebo (2 arms). Primary endpoint: Fecal incontinence. Started Dec 2019; status: completed.
02
Drugs
risperidone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on IRCT20200203046352N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200203046352N1.